Systematic review: Do we need a new gastro-oesophageal reflux disease questionnaire?

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 5, 2004, Pages 463-479

  Stanghellini, V ^a   Armstrong, D ^b   Monnikes H ^c   Bardhan, K D ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

^c HUMBOLDT UNIVERSITY   (Germany)

^d ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROESOPHAGEAL REFLUX; HUMAN; INSTRUMENT; LANGUAGE; MEDICAL LITERATURE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; REVIEW; SELF EVALUATION; SYMPTOM;

DYSPEPSIA; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HEALTH STATUS INDICATORS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 1642381160     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2004.01861.x     Document Type: Review

References (77)

1. Holtmann G. Reflux disease: the disorder of the third millennium. Eur J Gastroenterol Hepatol 2001; 13(Suppl. 1): S5-11.
2. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987; 40: 171-8.
3. Joelsson B, Johnsson F. Heartburn - the acid test. Gut 1989; 30: 1523-5.
4. Dent J, Brun J, Fendrick AM, et al. on behalf of the Genval Workshop Group. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44(Suppl. 2): S1-16.
5. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112(5): 1448-56.
6. Galmiche JP, Bruley des Varannes S. Symptoms and disease severity in gastro-oesophageal reflux disease. Scand J Gastroenterol Suppl 1994; 201: 62-8.
7. Baldi F, Ferrarini F, Longanesi A, Ragazzini M, Barbara L. Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci 1989; 34: 1890-3.
8. Klauser AG, Schindlebeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal disease. The Lancet 1990; 335: 205-8.
9. Jenkinson LR, Norrsi TL, Watson A. Symptoms and endoscopic findings - can they predict abnormal nocturnal acid gastrooesophageal reflux? Ann R Coll Surg Engl 1989; 71: 117-9.
10. Carlsson R, Holloway RH. Endoscopy-negative reflux disease. Bailliere Clin Gastroenterol 2000; 14: 827-37.
11. Colin R. Stratégie diagnostique du reflux-gastro-œsophagien et test thérapeutique. Gastroenterol Clin Biol 1999; 23: 537-44.
12. Stanghellini V, Cogliandro R, Cogliandro L, De Giorgio R, Barbara G, Corinaldesi R. Unsolved problems in the management of patients with gastroesophageal reflux disease. Dig Liv Dis 2003; 35: 843-8.
13. Armstrong D, Pare P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Am J Gastroenterol 2001; 96: 2849-57.
14. Irvine EJ, Feagan BG, Wong CJ. Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol 1996; 49(10): 1177-85.
15. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118(8): 622-9.
16. Kleinman L, Leidy NK, Crawley J, Bonomi A, Schoenfeld P. A comparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire. Med Care 2001; 39(2): 181-9.
17. Glise H, Wiklund I. Measurement of the impact of heartburn and dyspepsia on quality of life. Aliment Pharmacol Ther 1997; 11: 73-7.
18. Rentz AM, Battista C, Trudeau E, et al. Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies. Pharmacoeconomics 2001; 19: 349-63.
19. Osoba D. Guidelines for measuring health-related quality of life in clinical trials. In: Staquet MJ, Hays RD, Faysers PM, eds. Quality of Life Assessment in Clinical Trials. Oxford: Oxford University Press. 1998: 19-35.
20. Osoba D. Measuring the effect of cancer on quality of life. In: Osoba D, ed. Effect of Cancer on Quality of Life. Boca Raton, FL: CRC Press, 1991: 25-40.
21. Osoba D, Aarooson NK, Till JE. A practical guide for selecting quality-of-life measures in clinical trials and practice. In: Osoba D, ed. Effect of Cancer on Quality of Life. Boca Raton, FL: CRC Press, 1991: 89-111.
22. Guyatt G, Townsend M, Berman L, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chron Dis 1987; 40: 1129-233.
23. Greatorex R, Thorpe JA. Clinical assessment of gastro-oesophageal reflux by questionnaire. Br J Clin Pract 1983; 37(4): 133-5.
24. Reidel WL, Clouse RE. Variations in clinical presentation of patients with esophageal contraction abnormalities. Dig Dis Sci 1985; 30(11): 1065-71.
25. Andersen LI, Madsen PV, Dalgaard P, Jensen G. Validity of clinical symptoms in benign esophageal disease, assessed by questionnaire. Acta Med Scand 1987; 221(2): 171-7.
26. Dimenäs E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-7.
27. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129-34.
28. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001; 96(7): 1998-2004.
29. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7(1): 75-83.
30. Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 1991; 8: 965-70.
31. Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 1991; 26(1): 73-81.
32. Räihä IJ, Impivaara O, Seppala M, Sourander LB. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J Am Geriatr Soc 1992; 40(12): 1209-11.
33. Johnsson F, Roth Y, Damgaard Pedersen NE, Joelsson B. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther 1993; 7(1): 81-6.
34. Orenstein SR, Cohn JF, Shalaby TM, Kartan R. Reliability and validity of an infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila) 1993; 32(8): 472-84.
35. Orenstein SR, Shalaby TM, Cohn JF. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila) 1996; 35(12): 607-14.
36. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69(6): 539-47.
37. Williford WO, Krol WF, Spechler SJ. Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). Control Clin Trials 1994; 15(5): 335-48.
38. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33(10): 1023-9.
39. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998; 12: 1067-78.
40. Shaw MJ, Beebe TJ, Adlis A, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther 2001; 15: 981-7.
41. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93(10): 1816-22.
42. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 11: 671-4.
43. Manterola C, Munoz S, Grande L, Riedemann P. Construction and validation of a gastroesophageal reflux symptom scale. Preliminary report. Rev Med Chil 1999; 127(10): 1213-22.
44. Manterola C, Munos S, Grande L, Bustbos L. Initial validation of a questionnaire for detecting gastroesophageal reflux disease in epidemiological settings. J Clin Epidemiol 2002; 55: 1041-5.
45. Allen CJ, Parameswaran K, Belda J, Anvari M. Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus 2000; 13(4): 265-70.
46. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 2001; 46(7): 1540-9.
47. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96(1): 52-7.
48. Ofman JJ, Shaw M, Sadik K, et al. Identifying patients with gastroesophageal reflux disease. Dig Dis Sci 2002; 47: 1863-9.
49. Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wender NK, Mattson ME, Furberg CD, et al., eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, NY: Le Jacq. 1984: 170-83.
50. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
51. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
52. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40-66.
53. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 1995; 82: 216-22.
54. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996; 183(3): 217-24.
55. Velanovich V. Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg 1998; 2(2): 141-5.
56. Velanovich V, Karmy-Jones R. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters. Am Surg 1998; 64(7): 649-53.
57. Young TL, Kirchdoerfer LJ, Osterhaus JT. A development and validation process for a disease-specific quality of life instrument. Drug Inf J 1996; 30: 185-93.
58. Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998; 583: 41-9.
59. Jasani K, Piterman L, McCall L. Gastroesophageal reflux and quality of life. Patient's knowledge, attitudes and perceptions. Aust Fam Physician 1999; 28(Suppl. 1): S15-8.
60. Raymond JM, Marquis P, Bechade D, et al. Assessment of quality of life of patients with gastroesophageal reflux. Elaboration and validation of a specific questionnaire. Gastroenterol Clin Biol 1999; 23(1): 32-9.
61. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment Questionnaire for Patients with Symptoms of Gastro-Esophageal Reflux Disease (WPAI-GERD) - results from a cross-sectional study. Value Health 2002; 5(2): 106-13.
62. Colwell HH, Mathias SD, Pasta DJ, Henning JM, Hunt RH. Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease: a validation study. Dig Dis Sci 1999; 44(7): 1376-83.
63. Mathias SD, Colwell HH, Miller DP, Pasta DJ, Henning JM, Ofman JJ. Health-related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine. Dig Dis Sci 2001; 46(11): 2416-23.
64. Mathias SD, Castell DO, Elkin EP, Matosian ML. Health-related quality of life of patients with acute erosive reflux esophagitis. Dig Dis Sci 1996; 41(11): 2123-9.
65. Eggleston A, Farup C, Meier R. The domestic/international gastroenterology surveillance study (DIGEST): design, subjects and methods. Scand J Gastroenterol 1999; 34(Suppl. 231): 9-14.
66. Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A. Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment. Dig Dis Sci 2002; 47: 1530-7.
67. Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999; 13(12): 1621-30.
68. Wiklund I, Bardhan KD, Muller-Lissner S, et al. Quality of life during acute and intermittent treatment of gastrooesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol 1998; 30: 19-27.
69. Blomqvist A, Lönroth H, Dalenbäck J, Ruth M, Wiklund I, Lundell L. Quality of life assessment after laparoscopic and open fundoplications. Scand J Gastroenterol 1996; 31: 1052-8.
70. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30(11): 1046-52.
71. Revicki DA, Sorensen S, Maton PN, Orlando RC. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis 1998; 16: 284-91.
72. Fass R, Fennerty MB, Vakil N. Nonerosive reflux disease - current concepts and dilemmas. Am J Gastroenterol 2001; 96(2): 303-14.
73. Galmiche JP, des Varannes SB. Endoscopy-negative reflux disease. Curr Gastroenterol Rep 2001; 3(3): 206-14.
74. Hauser W, Grandt D. [Measuring quality of life in gastroenterology - concepts, instruments and problems.] Z Gastroenterol 2001; 39(6): 475-81.
75. Galmiche JP, Letessier E, Scarpignato C. Treatment of gastro-oesophageal reflux disease in adults. Br Med J 1998; 316(7146): 1720-3.
76. Johannessen T, Petersen H, Kristensen P, et al. The intensity and variability of symptoms in dyspepsia. Scand J Prim Health Care 1993; 11(1): 50-5.
77. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper diaries. Br Med J 2002; 324: 1193-4.